Xtant Medical acquires nanOss production ops from RTI Surgical for $2M cash plus contingent payments

Xtant Medical Holdings, Inc.

Acquired equipment and inventory from RTI Surgical's synthetic bone graft business for $2M cash plus contingent payments based on future nanOss product sales.
Assumed lease for the nanOss production facility in Greenville, NC.
Previously acquired nanOss distribution rights and IP from Surgalign in August 2023.
CEO Sean Browne says full control will revive and grow nanOss, improving manufacturing capabilities and cash flows.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.